243 related articles for article (PubMed ID: 35549943)
1. Sustained correction of hippocampal neurogenic and cognitive deficits after a brief treatment by Nutlin-3 in a mouse model of fragile X syndrome.
Javadi S; Li Y; Sheng J; Zhao L; Fu Y; Wang D; Zhao X
BMC Med; 2022 May; 20(1):163. PubMed ID: 35549943
[TBL] [Abstract][Full Text] [Related]
2. MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome.
Li Y; Stockton ME; Bhuiyan I; Eisinger BE; Gao Y; Miller JL; Bhattacharyya A; Zhao X
Sci Transl Med; 2016 Apr; 8(336):336ra61. PubMed ID: 27122614
[TBL] [Abstract][Full Text] [Related]
3. Increased Training Intensity Induces Proper Membrane Localization of Actin Remodeling Proteins in the Hippocampus Preventing Cognitive Deficits: Implications for Fragile X Syndrome.
Martinez LA; Tejada-Simon MV
Mol Neurobiol; 2018 Jun; 55(6):4529-4542. PubMed ID: 28688003
[TBL] [Abstract][Full Text] [Related]
4. Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.
Bilousova TV; Dansie L; Ngo M; Aye J; Charles JR; Ethell DW; Ethell IM
J Med Genet; 2009 Feb; 46(2):94-102. PubMed ID: 18835858
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
[TBL] [Abstract][Full Text] [Related]
6. Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice.
Dansie LE; Phommahaxay K; Okusanya AG; Uwadia J; Huang M; Rotschafer SE; Razak KA; Ethell DW; Ethell IM
Neuroscience; 2013 Aug; 246():186-98. PubMed ID: 23660195
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
[TBL] [Abstract][Full Text] [Related]
8. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
[TBL] [Abstract][Full Text] [Related]
9. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
[TBL] [Abstract][Full Text] [Related]
10. Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome.
Li Y; Stockton ME; Eisinger BE; Zhao Y; Miller JL; Bhuiyan I; Gao Y; Wu Z; Peng J; Zhao X
Nat Commun; 2018 Jun; 9(1):2494. PubMed ID: 29950602
[TBL] [Abstract][Full Text] [Related]
11. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
[TBL] [Abstract][Full Text] [Related]
12. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
[TBL] [Abstract][Full Text] [Related]
13. Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome.
Morrill NK; Joly-Amado A; Li Q; Prabhudeva S; Weeber EJ; Nash KR
Exp Neurol; 2022 Nov; 357():114170. PubMed ID: 35863501
[TBL] [Abstract][Full Text] [Related]
14. Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome.
King MK; Jope RS
Genes Brain Behav; 2013 Oct; 12(7):723-31. PubMed ID: 23941202
[TBL] [Abstract][Full Text] [Related]
15. Sex-specific modulation of early life vocalization and cognition by Fmr1 gene dosage in a mouse model of Fragile X Syndrome.
Giua G; Iezzi D; Caceres-Rodriguez A; Strauss B; Chavis P; Manzoni OJ
Biol Sex Differ; 2024 Feb; 15(1):18. PubMed ID: 38383408
[TBL] [Abstract][Full Text] [Related]
16. Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesis.
Raj N; McEachin ZT; Harousseau W; Zhou Y; Zhang F; Merritt-Garza ME; Taliaferro JM; Kalinowska M; Marro SG; Hales CM; Berry-Kravis E; Wolf-Ochoa MW; Martinez-Cerdeño V; Wernig M; Chen L; Klann E; Warren ST; Jin P; Wen Z; Bassell GJ
Cell Rep; 2021 Apr; 35(2):108991. PubMed ID: 33852833
[TBL] [Abstract][Full Text] [Related]
17. Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome.
Yuskaitis CJ; Beurel E; Jope RS
Biochim Biophys Acta; 2010 Nov; 1802(11):1006-12. PubMed ID: 20600866
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
19. BDNF in fragile X syndrome.
Castrén ML; Castrén E
Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
[TBL] [Abstract][Full Text] [Related]
20. Agmatine relieves behavioral impairments in Fragile X mice model.
Jeon SJ; Kwon H; Bae HJ; Gonzales EL; Kim J; Chung HJ; Kim DH; Ryu JH; Shin CY
Neuropharmacology; 2022 Nov; 219():109234. PubMed ID: 36057317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
